Key result
Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis and improves cardiac function after myocardial infarction by reducing p53 degradation via OTUB1.
Why the study?
ASPP1 was previously shown to promote cardiomyocyte apoptosis via p53 nuclear trafficking, but its influence on myocardial fibrosis and the underlying mechanisms remained unknown.
Does deletion of ASPP1 reduce myocardial fibrosis and improve cardiac function after myocardial infarction in mice?
Does deletion of ASPP1 reduce myocardial fibrosis and improve cardiac function after myocardial infarction in mice?
Deletion of ASPP1 in myofibroblasts alleviates cardiac fibrosis and improves heart function after myocardial infarction by promoting the ubiquitination and degradation of p53.
Answers are grounded in this paper and cite their sources.
Suggests ASPP1 as antifibrotic target in mouse MI; leaves open any human therapeutic translation.
In the healing process of myocardial infarction, cardiac fibroblasts are activated to produce collagen, leading to adverse remodeling and heart failure. Our previous study showed that ASPP1 promotes cardiomyocyte apoptosis by enhancing the nuclear trafficking of p53. We thus explored the influence of ASPP1 on myocardial fibrosis and the underlying mechanisms. Here, we observed that ASPP1 was increased after 4 weeks of MI. Both global and myofibroblast knockout of ASPP1 in mice mitigated cardiac dysfunction and fibrosis after MI. Strikingly, ASPP1 produced the opposite influence on p53 level and cell fate in cardiac fibroblasts and cardiomyocytes. Knockdown of ASPP1 increased p53 levels and inhibited the activity of cardiac fibroblasts. ASPP1 accumulated in the cytoplasm of fibroblasts while the level of p53 was reduced following TGF-β1 stimulation; however, inhibition of ASPP1 increased the p53 level and promoted p53 nuclear translocation. Mechanistically, ASPP1 is directly bound to deubiquitinase OTUB1, thereby promoting the ubiquitination and degradation of p53, attenuating myofibroblast activity and cardiac fibrosis, and improving heart function after MI. ASPP1 promotes apoptosis of cardiomyocytes by increasing the trafficking of p53 to the nucleus. Here the authors show that, in fibroblasts, ASPP1 promotes the ubiquitination and degradation of p53, decreasing myofibroblast activity and improving cardiac fibrosis and function after myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied Myocardial infarction and cardiac fibrosis. ASPP1 deletion vs. Wild-type or control was evaluated on Cardiac fibrosis and function (ejection fraction, fractional shortening, infarct size). Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis and improves cardiac function after myocardial infarction by reducing p53 degradation via OTUB1.
Synapse has enriched 10 related papers. Consider them for comparative context: